NCT03923634View on ClinicalTrials.gov

Princess® RICH for the Correction of Fine Lines

NACompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

October 16, 2018

Primary Completion Date

April 29, 2019

Study Completion Date

October 22, 2019

Conditions
Lateral Canthal LinesPerioral Rhytids
Interventions
DEVICE

Princess® RICH

Princess® RICH is injected into lateral canthal lines and/or perioral rhytids

Trial Locations (3)

Unknown

MaRa-Medical Aesthetic Research Academy, Graz

Medizinische Universität-Klinikum für Dermatologie und Venerologie, Graz

YUVELL, Vienna

Sponsors

Lead Sponsor

Croma-Pharma GmbH
All Listed Sponsors
lead

Croma-Pharma GmbH

INDUSTRY

NCT03923634 - Princess® RICH for the Correction of Fine Lines | Biotech Hunter | Biotech Hunter